The FNUSA-ICRC team co-authors the best Czech scientific article in cardiology of 2017

MUDr. Ota Hlinomaz, CSc. FNUSA-ICRC

Press release, 21 June 2018, Brno

The Cardiology Team of the International Clinical Research Centre at St. Anne’s University Hospital Brno (FNUSA-ICRC), led by MUDr. Ota Hlinomaz, CSc., made an extraordinary achievement. For the second time, two members of the team co-authored a scientific article in a prestigious foreign magazine, which won the award for the best Czech publication in the field of cardiology at the Annual Congress of the Czech Society of Cardiology.

MUDr. Ota Hlinomaz, CSc., Acute Coronary Syndromes Research Group, received two awards for the best cardiology publications published in the previous year – The Best of Czech Cardiology at this year’s Annual Congress of the Czech Society of Cardiology in Brno. He received the first prize as a co-author for publishing the PRAGUE-18 study that compared new blood-anticoagulant drugs in patients with acute myocardial infarction in whom doctors surgically corrected narrowed sections or completely closed the coronary arteries supplying the heart muscle. In addition, the Brno-based cardiologist was awarded the third prize for publishing research in which experts compared two treatment methods for restenosis (note: the recurrence of a narrowing of a blood vessel) in the stent (note: a metal reinforcement, spiral).

Led by prof. Zuzana Moťovská Ph.D. from Vinohrady University Hospital in Prague, the PRAGUE-18 study involved 1230 patients from 14 Czech health centres. “The study was designed to compare new blood-anticoagulant drugs – Prasugrel and Ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. The study did not find any significant difference between the drugs studied,” summarises MUDr. Ota Hlinomaz, CSc., who participated on publishing the study as the first co-author. The second study, involving a total of 136 patients, focused on comparing the efficacy of two treatment methods for blood-vessel restenosis in the stent.

“The aim of this study was to compare the efficacy of Paclitaxel eluting baloon catheters against drug-eluting stents in the treatment of stent restenosis. Paclitaxel-eluting baloon catheters had better results,” adds Brno-based cardiologist Ota Hlinomaz.

Both publications co-authored by MUDr. Ota Hlinomaz were also published in prestigious foreign scientific journals. The winning PRAGUE-18 study was published in the Journal of the American College of Cardiology (JAAC), and the study that took the third place was published in the Circulation: Cardiovascular Interventions journal.

“For every scientist or doctor, it is a prestigious achievement to have a paper published in JAAC, Circulation, or any other renowned foreign scientific journal. Such articles tend to be frequently cited, which also increases the scientific reputation of the given institution at which the scientists or doctors work,” explains Gorazd B. Stokin, FNUSA-ICRC Chair.

The Journal of the American College of Cardiology is the world’s most widely read journal in the field of cardiovascular medicine and it has an international reputation for excellent quality. JACC journals publish peer-reviewed articles on all aspects of cardiovascular disease that comment on the research being presented, including various clinical studies and translational examinations.

The Circulation: Cardiovascular Interventions journal is one of six journals of the American Heart Association. In terms of content, it focuses on heart disease, imaging methods, arrhythmia, electrophysiology and genetics.


The International Clinical Research Centre at St. Anne’s University Hospital Brno (FNUSA-ICRC) is a prestigious international project that was founded in the Czech Republic in 2011. Funded largely by national and international grants, the international centre focuses on research into heart and brain diseases in order to find new technologies, treatment procedures and methods and medicines for prevention, early diagnosis and individualised treatment. Currently, more than 300 researchers and doctors from the Czech Republic, the USA, Canada, Argentina and nearly 20 European Union currently participate in FNUSA-ICRC activities. In addition, FNUSA-ICRC collaborates on international research with scientists and academic institutions all over the world. For example, it collaborates with the University of California San Diego, University of South Florida, Mayo Clinic, the University of Medicine in Vienna, the Swedish Karolinska Institutet, or two Chinese university hospitals.